Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia (Q108396470)

1

0 references

Hashim Ali

2

0 references

Ilaria Secco

3

0 references

Elena Chiavacci

4

0 references

Guilherme Neves

5

0 references

Daniel Goldhill

6

0 references

Rebecca Penn

7

0 references

Jose M Jimenez-Guardeño

8

0 references

Ana M Ortega-Prieto

9

0 references

Rossana Bussani

10

0 references

Antonio Cannatà

11

0 references

Giorgia Rizzari

12

0 references

Chiara Collesi

13

0 references

Edoardo Schneider

14

0 references

Daniele Arosio

15

0 references

Ajay M Shah

16

0 references

Wendy S Barclay

17

0 references

Michael H Malim

18

0 references

Juan Burrone

19

0 references

Mauro Giacca

describes a project that uses

20

0 references

language of work or name

English

0 references

publication date

June 2021

0 references

published in

Nature

0 references

volume

594

0 references

issue

7861

0 references

page(s)

88-93

0 references

ImageJ

1 reference

Europe PubMed Central

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC7611055/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

cites work

A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Calcium-dependent phospholipid scrambling by TMEM16F

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

3 September 2021

Antiparasitic therapy

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

TMEM16A confers receptor-activated calcium-dependent chloride conductance

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

TMEM16F forms a Ca2+-activated cation channel required for lipid scrambling in platelets during blood coagulation

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Ultrasensitive fluorescent proteins for imaging neuronal activity

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Activation of the Cl- channel ANO1 by localized calcium signals in nociceptive sensory neurons requires coupling with the IP3 receptor

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Block by fluoxetine of volume-regulated anion channels

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner.

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Molecular mediators of macrophage fusion

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Differential effects of anoctamins on intracellular calcium signals.

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

The biology and toxicology of molluscicides, Bayluscide

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Endogenous calcium channels in human embryonic kidney (HEK293) cells

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

TMEM16A Contributes to Endothelial Dysfunction by Facilitating Nox2 NADPH Oxidase-Derived Reactive Oxygen Species Generation in Hypertension

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Older versus newer antidepressants: substance P or calcium antagonism?

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Cell-surface phosphatidylserine regulates osteoclast precursor fusion

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

TMEM16F-Mediated Platelet Membrane Phospholipid Scrambling Is Critical for Hemostasis and Thrombosis but not Thromboinflammation in Mice-Brief Report.

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Regulation of STIM1/Orai1-dependent Ca2+ signalling in platelets.

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial.

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Calmodulin-dependent activation of the epithelial calcium-dependent chloride channel TMEM16A

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Modulation of phosphatidylserine epitope expression by BeWo cells during forskolin treatment

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

TMEM16A Ca2+-activated Cl- channel inhibition ameliorates acute pancreatitis via the IP3R/Ca2+/NFκB/IL-6 signaling pathway

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Phosphatidylserine on viable sperm and phagocytic machinery in oocytes regulate mammalian fertilization

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Inhibition of TMEM16A Ca2+-activated Cl- channels by avermectins is essential for their anticancer effects

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Anoctamin 5/TMEM16E facilitates muscle precursor cell fusion

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Clinical Characteristics of Covid-19 in New York City

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

COVID-19 cytokine storm: the interplay between inflammation and coagulation

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Coagulation abnormalities and thrombosis in patients with COVID-19

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

TMEM16F phospholipid scramblase mediates trophoblast fusion and placental development

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Priming Time: How Cellular Proteases Arm Coronavirus Spike Proteins

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6

Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation

3 September 2021

1 reference

https://api.crossref.org/works/10.1038/S41586-021-03491-6